Waters Corporation (WAT) is a prominent player in the global analytical instruments and laboratory solutions market, boasting a market cap of $20.2 billion. The company operates through its Waters and TA Divisions, offering high-performance liquid chromatography, mass spectrometry, and thermal analysis systems to a wide range of customers in the pharmaceutical, life science, industrial, and governmental sectors.
As a large-cap stock with a market value exceeding $10 billion, Waters Corporation has established itself as a leader in the industry. Its innovative products cater to research, development, and quality assurance applications for customers across Asia, the Americas, and Europe.
Despite its strong position in the market, Waters Corporation’s stock has experienced a decline in recent months. Shares have fallen by 19.9% from their 52-week high of $423.56, underperforming the Health Care Select Sector SPDR Fund (XLV), which saw a 9.3% dip during the same period. In the longer term, WAT stock is down 8.5% year-to-date, although it has returned 15.3% over the past 52 weeks, outperforming XLV’s 8.7% decline during the same period.
The stock has been trading below its 200-day moving average since April, indicating a bearish trend. Despite reporting better-than-expected Q1 2025 adjusted EPS of $2.25 and revenue of $661.7 million, investor concerns over macroeconomic uncertainties and tariff impacts led to a 2.7% drop in WAT shares on May 6. However, the company raised its full-year adjusted EPS guidance to $12.75 – $13.05 and constant currency sales growth to 5% – 7%.
In comparison to its rival, Thermo Fisher Scientific Inc. (TMO), Waters Corporation has outperformed, with TMO stock falling 31% over the past 52 weeks and 24.5% year-to-date. Despite its strong performance, analysts remain cautiously optimistic about the stock’s prospects. With a consensus rating of “Moderate Buy” from 18 analysts, the stock is currently trading below the mean price target of $393.
In conclusion, Waters Corporation continues to be a key player in the analytical instruments and laboratory solutions market, with a strong presence globally. While the stock has faced some challenges in recent months, the company’s solid financial performance and innovative product offerings position it well for future growth. Investors should keep a close eye on developments in the industry and macroeconomic conditions to make informed decisions about investing in WAT stock.
